Gwangju Shinsegae Eye Clinic, Ranked No.1 in Korea Consumer Satisfaction Index for 5 Consecutive Years View original image


[Asia Economy Honam Reporting Headquarters Reporter Park Seon-gang] Gwangju Shinsegae Eye Clinic announced on the 8th that it has won the ‘2020 Korea Consumer Satisfaction Index No.1’ Customer Satisfaction Brand (Vision Correction category) award for five consecutive years, chosen directly by consumers.


Gwangju Shinsegae Eye Clinic was selected as the ‘2020 Korea Consumer Satisfaction Index No.1’ Customer Satisfaction Brand by achieving near-perfect scores in all criteria including medical technology, state-of-the-art equipment, and friendliness.


Shinsegae Eye Clinic introduced SMILE surgery without dry eye syndrome in 2013 and, having performed 30,000 surgeries, was recognized by Germany’s Carl Zeiss as a ‘LEADING SMILE CENTER’ and awarded ‘Best Skilled Surgeon in SMILE’.


It also won the ‘Korea Medical Service Vision Correction Award’ for two consecutive years and is well known as the number one hospital in cataract surgery in the Gwangju area (based on single ophthalmology clinics).


It has performed the most multifocal presbyopia and cataract surgeries in the Honam region and has introduced and operates CATALYS, a state-of-the-art laser cataract surgery device that does not require a blade.


In addition, it has contributed to the local community through various donations, including donating 100 million won to the Gwangju Community Chest of Korea, installing the Love Health Staircase at Sangmu Station of the Gwangju Subway, and participating in the Bitchang Contest.



Kim Jae-bong, CEO of Gwangju Shinsegae Eye Clinic, said, “We are very pleased to have won the award chosen directly by customers for five consecutive years,” and added, “We will continue to do our best to provide even higher medical services for safer and more perfect treatment and surgery.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing